Treatment of Antibiotic-ResistantHelicobacter pyloriInfection
- 2 July 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (1) , 53
- https://doi.org/10.1056/nejm199807023390116
Abstract
In 1996, several European gastroenterologists recommended that first-line treatment of Helicobacter pylori infection should consist of a proton-pump inhibitor combined with two of the following: clarithromycin, a nitroimidazole (metronidazole or tinidazole), and amoxicillin.1 In the case of treatment failure, either a second course of this triple regimen or quadruple therapy (omeprazole plus bismuth-based triple therapy) is advisable. However, because patient compliance with and tolerance of quadruple therapy is low, alternative treatments are needed for patients who have had no response to two or more courses of a standard triple regimen.Keywords
This publication has 3 references indexed in Scilit:
- The13C-urea breath test as a predictor of intragastric bacterial load and severity ofHelicobacter pylorigastritisScandinavian Journal of Clinical and Laboratory Investigation, 1998
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Antimicrobial Activity of RifabutinClinical Infectious Diseases, 1996